FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Wyeth | Prevnar | Pfizer | Prevnar-13
Syndicate content

FDA panel says yes to updated Prevnar

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!



Tools

The new Pfizer-Wyeth got good news Wednesday after an FDA panel determined that the company's updated version of childhood vaccine Prevnar is safe and effective.

In a 10-1 vote, the FDA's Vaccines and Related Biological Products Advisory Committee recommended Prevnar-13 as a safe, effective measure against diseases caused by the streptococcus pneumonia bacteria, including ear infections and pneumonia, according to Reuters. This updated Prevnar is designed to protect against six additional forms of the bacteria--up from the seven included in the original vaccine, which was approved in February 2000. An FDA decision on whether to approve the vaccine is expected by Dec. 30.

Prior to the vote, the FDA had questioned the updated vaccine's effectiveness in briefing documents, pointing out that the vaccine missed primary noninferiority immunogenicity criteria for serotypes 6B, 9V and 3 in the pivotal U.S. study.

The committee's decision comes a couple of weeks after Dutch authorities pulled a batch of Prevnar following the deaths of three infants.

- read the Reuters story
- check out the FDA's briefing documents

Related Articles:
Dutch pull Pfizer infant vaccine after deaths
FDA delays approval of Wyeth's Prevnar-13
Fewer Prevnar jabs just as effective
Vaccine proves widely effective against meningitis
Whistleblowers allege problems with Wyeth's Prevnar


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:
Comments (1) |
More stories about Wyeth   Prevnar   Pfizer   Prevnar-13  

Comments

How do they know that a vaccine that has not been put into use is either safe or effective? It has been widely shown that Pharma's in-house studies are not to be trusted in all their product lines.